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Abstract: Methicillin-resistant Staphylococcus aureus isolated from the nares of school going children (CA-MRSA) 
has been found to produce bacteriocin like inhibitory substance tentatively termed staphylococcin. It has a broad 
activity spectrum against many Gram positive bacteria including Staphylococcus aureus which suggests that the 
protein molecule can be used as an alternative for antibiotics. In this regard, the bacteriocin was studied for its 
immunological and toxicological properties in experimental mice. The antigenicity/immunogenicity of bacteriocin 
was assayed by ouchterlony technique. Accordingly, staphylococcin is antigenic ally poor, in the mice immune 
system and the antibody titre was not found to be significant in the ouchterlony technique. The acute and chronic 
toxic studies do not show any toxic effects in laboratory mice when injected with different doses of bacteriocin (20, 
40, 60 and 80μg/ml). Hematological studies with staphylococcin showed a marginal increase in lymphocyte count in 
the test animal groups. Further, different doses of staphylococcin showed no significant biochemical changes in the 
normal profile of mice blood biochemistry. 
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1. Introduction 
 
Bacteriocins are antibacterial proteins produced by 
bacteria that kill or inhibit the growth of other bacteria. 
These proteins and peptides are generally active against 
species closely related to the producing microorganism 
(Saeed, 2004). 
There are a large and increasing number of 
therapeutic proteins approved for clinical use and much 
more are undergoing preclinical studies and clinical 
trials in humans. Virtually, all therapeutic proteins elicit 
some level of antibody response which in some cases 
can lead to potentially serious side effects. Therefore, 
Immunogenicity of therapeutic proteins is a concern for 
clinicians, manufacturers and regulatory agencies. In 
order to assess immunogenicity of these molecules, 
appropriate detection quantitation and characterization 
of antibody response are necessary. So in this study, the 
antibacterial peptide staphylococcin was isolated and its 
immunogenic nature was analyzed by immunodiffusion 
test and its effect on the hematological and biochemical 
parameters on laboratory mice too was monitored for 
one month. 
Staphylococcus aureus has long been recognized as 
an important pathogen in human disease. Due to an 
increasing number of infections caused by MRSA 
strain, which are now often multidrug resistant therapy 
has become problematic so an alternative treatment 
methodology is the need of the hour where the 
bacteriocins prove to be an effective alternatives and 
nasal carriage of Staphylococcus aureus has been 
identified as a risk factor for community acquired 
infection (Creech, 2005). So, the Staphylococcus 
aureus strains were got from the nares of school going 
children and their bacteriocin production was assayed 
and further, the protein molecule was studied by 
immunological and toxicological tests. 
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2. Materials and Methods 
 
2.1 Microbial Cultures 
The methicillin resistant Staphylococcus aureus 
were isolated from the anterior nares of the school 
going children. Swabs were collected aseptically, 
transported to the laboratory using peptone broth as 
transport media and were plated on mannitol salt agar 
(MSA) and mannitol fermenting colonies were selected 
and screened for Staphylococcus aureus by performing 
various biochemical tests, the screened isolates were 
subjected to oxacillin salt screening and oxacillin disc 
diffusion. PCR assay was done to confirm their, 
resistant nature towards methicillin (CLSI, 2006). 
 
2.2 Partial Purification of Bacteriocin 
The MRSA stains were used for the production of 
bacteriocin. It was grown on Brain heart infusion broth 
at 37˚C for 24 hrs. The bacterial cells were removed by 
centrifugation at 10,000 rpm for 10 minutes at 4˚C. The 
supernatant was filtered and precipitated by using 80% 
ammonium sulphate and the system was held overnight 
at 4˚C and the precipitate was recovered by 
centrifugation at 15,000 rpm for 30 minutes at 4˚C and 
the pellet was dissolved in phosphate buffer and is 
designated as crude bacteriocin. The antibacterial 
activity was assayed by the agar well diffusion method 
and it was found to be effective in controlling the 
growth of MRSA. 
 
2.3 Ouchterlony 
Plate ouchterlony was performed in 1% agarose in 
sodium barbital buffer (pH 7.0) control wells contained 
BSA and anti BSA. Test wells, central wells contain 
first dose of antigen, while slide wells contain pre-
immune serum and first, second and third sera, 
respectively. 
 
2.4 Toxic Studies in Rabbits 
The animals were randomly divided into 5 groups 
of 4 animals, each. Group 1, animals served as controls 
and received normal saline (0.4). Group 2, 3 and 4 
animals were treated with intravenous injections of 20, 
40, 60 and 80μg/kg body weight of the bacteriocin. 
Blood samples were drawn from each member of all 
groups. Toxic manifestations like abnormal motor 
activity alteration in water or food intake, respiration 
body temperature, diarrhea and mortality were observed 
for (1, 2, 6 and 2 hours) for acute toxicity and 1 month 
for chronic toxicity studies. Before the first and last 
treatment, blood samples were collected from each 
animal in syringes containing sodium citrate as 
anticoagulant and hematological and biochemical tests 
were performed at the beginning and the end of the 
experiment (Schellens, 2002). 
 
3. Results and Discussion 
 
Staphylococcin produced by CA-MRSA was 
checked for its antibacterial activity and was found to 
be strongly active from the zone of inhibition produced. 
Animal models were used to predict the Immunogenic 
and toxigenic nature of the protein for humans reliably. 
In nonhuman primate studies, a variety of responses are 
noted including from little or no antibody response. 
Ouchterlony test of the bacteriocin was performed to 
check its antigenicity were no lines of precipitation 
were observed but when it reacted with mice antisera 
taken after immunization with different doses of 
bacteriocin. 
However, normal precipitation was seen in control 
but further more sensitive ELISA test has to be 
performed to exactly analyze the grade of antigenicity 
and immunogenicity (Bussiere, 2003).  
For the toxicological studies of bacteriocin when 
mice were injected with varying concentration no 
abnormal effects (i.e.) abnormal motor activity 
sedation, hyphosis, changes in respiration and body 
weight was found in both controls and test groups. Food 
and water intake was also found to be normal. 
The biochemical parameters & hematological 
parameters too were not affected (Table 1 and 2) which 
shows that the bacteriocin has no adverse side effects 
on mice blood biochemistry. Hence, this study 
demonstrates the evidence of toxicological; 
immunological and biochemical studies of 
staphylococcal bacteriocin (staphylococcin) concluded 
staphylococcin did not show any toxicological effects. 
On that ground, it seems plausible that the hypothetical 
staphylococcin could act as potential reservoirs of 
therapeutic interventions. 
 
Table 1. Blood biochemistry of mice. 
 
S. No. Group Dosage Blood Glucose Total Lipid Total Protein A/G Ratio 
1. Control 0.4µl 86 mg mL-1 180 6.0 3.6 
2. Group 1 20µl 126 mg mL-1 180 6.5 3.6 
3. Group 2 40µl 130 mg mL-1 162 6.0 2.8 
4. Group 3 60µl 135 mg mL-1 172 6.8 2.5 
5. Group 4 80µl 125 mg mL-1 250 6.1 2.4 
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Table 2. Haematological parameters in mice. 
 
S. No. Group Dosage Hemoglobin ESR Leukocyte Count Erythrocyte Count WBC 
1. Control 0.4µl 10.7 5.04 32 2 7.0 
2. Group 1 20µl 11.7 5.01 34 4 8.8 
3. Group 2 40µl 13.0 5.70 50 1 5.5 
4. Group 3 60µl 11.0 4.70 65 5 6.7 
5. Group 4 80µl 10.0 4.20 62 8 6.6 
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